ArticleNature cancer2020

Mutational landscape influences immunotherapy outcomes among patients with non-small-cell lung cancer with human leukocyte antigen supertype B44.

Amy L Cummings et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.